HEADER HYDROLASE 08-AUG-02 1ME6 TITLE CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE FROM TITLE 2 PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN II; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 125-453; COMPND 5 SYNONYM: ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 6 EC: 3.4.23.39; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: PF00026; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS PROTEIN-LIGAND COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.FREIRE,A.G.NEZAMI,L.M.AMZEL REVDAT 4 11-OCT-17 1ME6 1 REMARK REVDAT 3 13-JUL-11 1ME6 1 VERSN REVDAT 2 24-FEB-09 1ME6 1 VERSN REVDAT 1 20-JAN-04 1ME6 0 JRNL AUTH E.FREIRE,A.G.NEZAMI,L.M.AMZEL JRNL TITL CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE JRNL TITL 2 FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED JRNL TITL 3 INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.8 REMARK 3 NUMBER OF REFLECTIONS : 26905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1441 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.576 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ME6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1000016848. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUL-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28346 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1SME REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, SODIUM PHOSPHATE, PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.60667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.21333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 65.21333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.60667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4820 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 97.82000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N ASP A 235 O HOH A 924 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 14 -50.88 -146.49 REMARK 500 GLN A 26 -81.78 -45.50 REMARK 500 GLN A 27 76.26 59.10 REMARK 500 TYR A 66 155.76 -47.71 REMARK 500 LYS A 68 153.09 -35.77 REMARK 500 ASP A 69 -68.14 -149.86 REMARK 500 SER A 135 81.36 20.43 REMARK 500 PRO A 138 152.43 -43.58 REMARK 500 GLN A 146 24.80 -73.67 REMARK 500 HIS A 161 -68.90 -21.16 REMARK 500 ASP A 190 53.93 -93.16 REMARK 500 LEU A 191 -83.50 -116.05 REMARK 500 VAL A 201 -83.28 -106.65 REMARK 500 GLN A 232 -74.24 -52.22 REMARK 500 PRO A 240 131.66 -39.14 REMARK 500 PHE A 241 11.02 58.45 REMARK 500 PRO A 297 106.47 -37.74 REMARK 500 ASN A 328 135.97 -171.71 REMARK 500 GLN B 26 11.84 87.12 REMARK 500 GLN B 27 121.28 -37.05 REMARK 500 THR B 49 135.88 -21.16 REMARK 500 SER B 61 42.42 -90.08 REMARK 500 LYS B 62 27.67 -157.13 REMARK 500 THR B 65 11.18 -69.21 REMARK 500 TYR B 66 175.56 -56.06 REMARK 500 GLU B 67 85.05 176.02 REMARK 500 ASP B 69 -33.01 -157.02 REMARK 500 LEU B 90 96.01 -69.93 REMARK 500 LEU B 98 129.09 175.34 REMARK 500 PHE B 102 -162.98 -125.77 REMARK 500 LEU B 126 19.73 -157.74 REMARK 500 SER B 135 89.46 20.47 REMARK 500 HIS B 161 -74.64 -17.75 REMARK 500 LEU B 191 -85.86 -131.29 REMARK 500 LEU B 234 132.96 -178.83 REMARK 500 PRO B 240 109.72 -38.74 REMARK 500 PRO B 243 41.27 -81.18 REMARK 500 CYS B 285 166.21 176.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVS A 347 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVS B 348 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SME RELATED DB: PDB REMARK 900 THIS CONTAINS THE SAME PROTEIN COMPLEXED WITH PEPSTATIN A REMARK 900 RELATED ID: 1QS8 RELATED DB: PDB REMARK 900 THIS ENTRY CONTAINS THE SAME ENZYME FROM PLASMODIUM VIVAX DBREF 1ME6 A 1 329 UNP P46925 PLM2_PLAFA 125 453 DBREF 1ME6 B 1 329 UNP P46925 PLM2_PLAFA 125 453 SEQRES 1 A 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 A 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 A 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 A 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 A 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 A 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 A 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 A 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 A 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 A 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 A 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 A 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 A 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 A 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 A 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 A 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 A 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 A 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 A 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 A 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 A 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 A 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 A 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 A 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 A 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 A 329 LYS LYS ASN LEU SEQRES 1 B 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 B 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 B 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 B 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 B 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 B 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 B 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 B 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 B 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 B 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 B 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 B 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 B 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 B 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 B 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 B 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 B 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 B 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 B 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 B 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 B 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 B 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 B 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 B 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 B 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 B 329 LYS LYS ASN LEU HET IVS A 347 34 HET IVS B 348 34 HETNAM IVS 3-HYDROXY-6-METHYL-4-(3-METHYL-2-(3-METHYL-2-(3-METHYL- HETNAM 2 IVS BUTYRYLAMINO)-BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC HETNAM 3 IVS ACID ETHYL ESTER FORMUL 3 IVS 2(C25 H47 N3 O6) FORMUL 5 HOH *120(H2 O) HELIX 1 1 THR A 49 LEU A 53 5 5 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 PRO A 113 SER A 118 1 6 HELIX 5 5 PRO A 138 GLN A 146 1 9 HELIX 6 6 PRO A 223 LEU A 231 1 9 HELIX 7 7 GLU A 269 LEU A 274 1 6 HELIX 8 8 GLY A 302 LYS A 308 1 7 HELIX 9 9 THR B 49 LYS B 55 5 7 HELIX 10 10 ASP B 59 SER B 63 5 5 HELIX 11 11 THR B 108 GLU B 112 5 5 HELIX 12 12 PRO B 113 SER B 118 1 6 HELIX 13 13 TRP B 128 SER B 132 5 5 HELIX 14 14 PRO B 138 GLN B 146 1 9 HELIX 15 15 PRO B 223 ASN B 233 1 11 HELIX 16 16 GLU B 269 LEU B 274 1 6 HELIX 17 17 GLY B 302 ARG B 307 1 6 SHEET 1 A16 TRP A 41 PRO A 43 0 SHEET 2 A16 LEU A 96 ASP A 107 1 O ILE A 103 N VAL A 42 SHEET 3 A16 THR A 81 VAL A 93 -1 N SER A 83 O ASP A 107 SHEET 4 A16 LYS A 72 ASN A 76 -1 N VAL A 73 O GLY A 84 SHEET 5 A16 THR A 81 VAL A 93 -1 O VAL A 82 N MET A 75 SHEET 6 A16 MET A 15 VAL A 22 -1 O GLU A 21 N THR A 92 SHEET 7 A16 PRO A 28 ASP A 34 -1 O PHE A 29 N ALA A 20 SHEET 8 A16 GLY A 122 GLY A 125 1 N GLY A 122 O THR A 30 SHEET 9 A16 PRO A 28 ASP A 34 1 O THR A 30 N GLY A 122 SHEET 10 A16 MET A 15 VAL A 22 -1 O GLY A 18 N PHE A 31 SHEET 11 A16 GLU A 7 PHE A 11 -1 N VAL A 9 O TYR A 17 SHEET 12 A16 GLY A 166 ILE A 170 -1 O GLY A 166 N LEU A 8 SHEET 13 A16 LEU A 153 TYR A 157 -1 N THR A 155 O THR A 169 SHEET 14 A16 TYR A 309 ASP A 314 -1 O THR A 311 N PHE A 156 SHEET 15 A16 SER A 319 ALA A 325 -1 O SER A 319 N ASP A 314 SHEET 16 A16 TYR A 178 LYS A 186 -1 N GLU A 179 O LEU A 324 SHEET 1 B 7 LYS A 265 LEU A 268 0 SHEET 2 B 7 PHE A 257 THR A 260 -1 N PHE A 257 O LEU A 268 SHEET 3 B 7 GLN A 194 HIS A 200 -1 N ASP A 198 O THR A 260 SHEET 4 B 7 MET A 205 VAL A 213 -1 O LEU A 206 N ALA A 199 SHEET 5 B 7 THR A 298 LEU A 301 1 O PHE A 299 N ILE A 212 SHEET 6 B 7 ILE A 220 VAL A 222 -1 N THR A 221 O ILE A 300 SHEET 7 B 7 ILE A 289 GLY A 291 1 N ILE A 290 O ILE A 220 SHEET 1 C 4 ILE A 237 LYS A 238 0 SHEET 2 C 4 TYR A 245 LEU A 248 -1 N VAL A 246 O ILE A 237 SHEET 3 C 4 LEU A 284 MET A 286 -1 N CYS A 285 O THR A 247 SHEET 4 C 4 GLN A 275 HIS A 276 -1 N GLN A 275 O MET A 286 SHEET 1 D 9 GLY B 122 GLY B 125 0 SHEET 2 D 9 THR B 30 ASP B 34 1 O THR B 30 N GLY B 122 SHEET 3 D 9 MET B 15 ASP B 19 -1 O GLY B 18 N PHE B 31 SHEET 4 D 9 ASP B 4 PHE B 11 -1 O GLU B 7 N ASP B 19 SHEET 5 D 9 GLY B 166 ILE B 170 -1 O GLY B 166 N LEU B 8 SHEET 6 D 9 LEU B 153 TYR B 157 -1 N THR B 155 O THR B 169 SHEET 7 D 9 TYR B 309 ASP B 314 -1 O THR B 311 N PHE B 156 SHEET 8 D 9 SER B 319 ALA B 325 -1 O SER B 319 N ASP B 314 SHEET 9 D 9 TYR B 178 LYS B 186 -1 N GLU B 179 O LEU B 324 SHEET 1 E 4 TRP B 41 PRO B 43 0 SHEET 2 E 4 LEU B 96 ASP B 107 1 O ILE B 103 N VAL B 42 SHEET 3 E 4 GLY B 80 VAL B 93 -1 O SER B 83 N ILE B 106 SHEET 4 E 4 LYS B 68 TYR B 77 -1 N ASP B 69 O PHE B 86 SHEET 1 F 7 LYS B 265 LEU B 268 0 SHEET 2 F 7 PHE B 257 THR B 260 -1 N PHE B 257 O LEU B 268 SHEET 3 F 7 GLN B 194 VAL B 201 -1 N ASP B 198 O THR B 260 SHEET 4 F 7 ILE B 204 VAL B 213 -1 O ILE B 204 N VAL B 201 SHEET 5 F 7 THR B 298 LEU B 301 1 O PHE B 299 N ILE B 212 SHEET 6 F 7 ILE B 220 VAL B 222 -1 N THR B 221 O ILE B 300 SHEET 7 F 7 ILE B 289 GLY B 291 1 O ILE B 290 N VAL B 222 SHEET 1 G 4 ILE B 237 LYS B 238 0 SHEET 2 G 4 TYR B 245 LEU B 248 -1 N VAL B 246 O ILE B 237 SHEET 3 G 4 LEU B 284 MET B 286 -1 O CYS B 285 N THR B 247 SHEET 4 G 4 GLN B 275 HIS B 276 -1 O GLN B 275 N MET B 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.03 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.04 SSBOND 3 CYS B 47 CYS B 52 1555 1555 2.03 SSBOND 4 CYS B 249 CYS B 285 1555 1555 2.03 CISPEP 1 GLU A 112 PRO A 113 0 0.18 CISPEP 2 GLU B 112 PRO B 113 0 0.22 SITE 1 AC1 17 MET A 15 ASP A 34 GLY A 36 SER A 37 SITE 2 AC1 17 ASN A 76 VAL A 78 SER A 79 ILE A 123 SITE 3 AC1 17 ASP A 214 GLY A 216 THR A 217 SER A 218 SITE 4 AC1 17 ALA A 219 HOH A 808 HOH A 926 HOH A 927 SITE 5 AC1 17 PHE B 241 SITE 1 AC2 15 PHE A 241 LEU A 242 ASP B 34 GLY B 36 SITE 2 AC2 15 ASN B 76 TYR B 77 VAL B 78 SER B 79 SITE 3 AC2 15 ILE B 123 TYR B 192 ASP B 214 GLY B 216 SITE 4 AC2 15 THR B 217 SER B 218 ILE B 300 CRYST1 141.930 141.930 97.820 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007046 0.004068 0.000000 0.00000 SCALE2 0.000000 0.008136 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010223 0.00000